EUVIMEDEUVIMED entdecken
Open Access

Expression of melanocytic markers in uterine smooth muscle tumours

Yasamin Mirzabeigi iD, Amr Abulaban iD, Hisham F Bahmad iD, Matthew P Schlumbrecht iD, Andre Pinto iD

Histopathology · 2026-09 · 89 (3) · 504-511

DOI: 10.1111/his.70182 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Histopathology, online erschienen am 26.05.2026. Verfasst von Yasamin Mirzabeigi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, Fl, USA. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Uterine Neoplasms, Smooth Muscle Tumor. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims Uterine smooth muscle tumours (SMTs) conventionally express myogenic markers such as desmin, h‐caldesmon and smooth muscle actin by immunohistochemistry. In contrast, the frequency and extent of melanocytic marker (MM) expression, commonly assessed in the differential diagnosis with perivascular epithelioid cell tumours (PEComas), remain poorly defined. This study aimed to evaluate the positivity of MMs and Cathepsin K in a large cohort of SMTs. Methods and results In total, 102 tumours were retrospectively identified, including 72 leiomyomas of various subtypes, 4 cases of SMT of uncertain malignant potential and 26 leiomyosarcomas. Immunohistochemistry for HMB‐45, Melan‐A, PRAME and Cathepsin K was performed on whole‐tissue sections and assessed for the presence, extent and intensity of staining. A chi‐square test was used to determine statistical significance. Thirty‐eight tumours (37.2%) expressed at least one MM (excluding Cathepsin K). PRAME was the most frequently expressed marker (30/102, 29.4%), showing strong nuclear staining in 27 tumours (26%), predominantly in a focal distribution (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorUterine NeoplasmsSmooth Muscle TumorHumansFemaleRetrospective StudiesImmunohistochemistryAntigens, NeoplasmCathepsin KMiddle AgedAdultPerivascular Epithelioid Cell NeoplasmsMelanoma-Specific AntigensMART-1 AntigenLeiomyomaAgedLeiomyosarcoma

Stichwörter der Autor:innen

PEComagynaecological pathologyimmunohistochemistrymelanocytic markersuterine smooth muscle tumour

Substanzen

Biomarkers, TumorAntigens, NeoplasmCathepsin KMelanoma-Specific AntigensPRAME protein, humanMART-1 Antigen

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, Fl, USA.
  • Department of Obstetrics, Gynaecology and Reproductive Science, Division of Gynecologic Oncology, University of Miami Miller School of Medicine, Miami, Fl, USA.

ORCID-Profile: Yasamin Mirzabeigi, Amr Abulaban, Hisham F Bahmad, Matthew P Schlumbrecht, Andre Pinto

Zitieren

APA

Mirzabeigi, Y., Abulaban, A., Bahmad, H. F., Schlumbrecht, M. P., & Pinto, A. (2026). Expression of melanocytic markers in uterine smooth muscle tumours. Histopathology, 89(3), 504-511. https://doi.org/10.1111/his.70182

Vancouver

Mirzabeigi Y, Abulaban A, Bahmad HF, Schlumbrecht MP, Pinto A. Expression of melanocytic markers in uterine smooth muscle tumours. Histopathology. 2026;89(3):504-511. doi:10.1111/his.70182

BibTeX
@article{Mirzabeigi2026,
  author = {Mirzabeigi, Yasamin and Abulaban, Amr and Bahmad, Hisham F and Schlumbrecht, Matthew P and Pinto, Andre},
  title = {Expression of melanocytic markers in uterine smooth muscle tumours},
  journal = {Histopathology},
  year = {2026},
  volume = {89},
  number = {3},
  pages = {504--511},
  doi = {10.1111/his.70182}
}
Kostenlos starten →